Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07127354
PHASE4

The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality

Sponsor: The Cleveland Clinic

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn how GLP-1 and GIP agonists effect bowel preparation in patients scheduled for colonoscopies. The main questions it aims to answer are: * Does GLP-1 and GIP agonist increase the rate of inadequate bowel preparation? * Does the quality of bowel preparation differ in patients who hold vs. those who continue a single dose of their GLP-1 or GIP agonist medication? * Are there any differences in the rates of complications gastric aspiration in patients who hold vs. continue a single dose of their GLP-1 or GIP agonist medication?

Official title: The Impact of GLP-1 Agonist and GIP Agonist on Bowel Preparation Quality: A Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

132

Start Date

2025-08-01

Completion Date

2026-08

Last Updated

2025-12-04

Healthy Volunteers

Yes

Interventions

DRUG

Continue GLP/GIP

Continue GLP-1 or GIP-based therapy as prescribed prior to the procedure.

Locations (3)

Cleveland Clinic

Cleveland, Florida, United States

Cleveland Clinic

Cleveland, Florida, United States

Cleveland Clinic Weston

Weston, Florida, United States